MR Imaging Features of Amyloid-Related Imaging Abnormalities
Jerome Barakos(California Pacific Medical Center), Michael Grundman(University of San Diego), Clifford R. Jack(Mayo Clinic), H. Robert Brashear(Brigham and Women's Hospital), Achim Gass(Heidelberg University), Kristen Morris(Janssen (United States)), Gregory A. Rippon(Pfizer (United States)), Y Miaux, H. Michael Arrighi(Sunesis (United States)), Jochen B. Fiebach(Pathodiagnostik Berlin), Yuan Lü(Jazz Pharmaceuticals (United States)), Donatella Tampieri(Montreal Neurological Institute and Hospital), Ronald S. Black(Pfizer (United States)), Reisa A. Sperling(Harvard University), D Melançon(NeuroRx Research (Canada)), Stephen Salloway(Providence College)
Cited by 111
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k